| 06:50 – 08:00 |
Registration |
| 08:00 – 08:10 |
Opening Remarks |
| Session 4: Pediatric Rheumatology |
| 08:10 – 09:00 |
Lupus in Children and Adolescents |
Clarissa Pilkington, UK |
| 09:00 – 09:50 |
Autoinflammatory Diseases in Children* |
|
| 09:50 – 10:35 |
Industry Symposium 4 |
| 10:35 – 10:55 |
AdARRC™ Networking & Refreshment Break |
| Session 5: The Global Landscape of Rheumatic and Musculoskeletal Diseases (RMDs) |
| 10:55 – 11:45 |
Rheumatic and Musculoskeletal Diseases (RMDs) in the Asia-Pacific: An APLAR Perspective |
Sumaira Farman Raja, Pakistan |
| 11:45 – 12:35 |
Health Disparities in Rheumatic Diseases: Understanding Global Challenges in Africa and Proposing Strategies for Improvement |
Dzifa Dey, Ghana |
| 12:35 – 13:20 |
Industry Symposium 5 |
| 13:20 – 14:20 |
Lunch Break |
| Session 6: Combined Round |
| 14:20 – 15:10 |
EULAR 2022 Update: ANCA-Associated Vasculitis Management* |
|
| 15:10 – 16:00 |
Update on Treatment of Sjögren’s Syndrome |
Arthur Bookman, Canada |
| 16:00 – 16:45 |
Industry Symposium 6 |
| 16:45 – 17:05 |
AdARRC™ Networking & Refreshment Break |
| Parallel Focused Workshops |
| 17:05 – 18:05 |
Workshop 1: Challenging Lupus Cases: Bring Yours for Expert Discussion |
Clarissa Pilkington, UK |
| Workshop 2: The Assessment and Management of Bone Health in Pediatric-Onset Rheumatological Diseases From Early Age to Adulthood |
Sumaira Farman Raja, Pakistan |
| Workshop 3: The Use of Hydroxychloroquine During the Periconception Period and Pregnancy in Women With Autoimmune Diseases |
Dzifa Dey, Ghana |
| Workshop 4: Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjögren Syndrome |
Arthur Bookman, Canada |
| Workshop 5: Managing Complex Pediatric Autoinflammatory Diseases* |
|
| Workshop 6: Benralizumab vs Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis* |
|
| END OF DAY 3 |
